| Literature DB >> 26094792 |
Zbigniew Nowak1, Zofia Wańkowicz1, Krzysztof Laudanski2.
Abstract
BACKGROUND: It is a struggle to identify the most adaptive coping strategies with disease-mediated stress. Here, we hypothesize that intensity of coping strategies, including denial, in patients with end-stage renal disease (ESRD), varies with type of renal replacement therapy (RRT).Entities:
Mesh:
Substances:
Year: 2015 PMID: 26094792 PMCID: PMC4482183 DOI: 10.12659/MSM.893331
Source DB: PubMed Journal: Med Sci Monit ISSN: 1234-1010
Demographic and clinical variables among studied groups.
| HD | CAPD | p | ||
|---|---|---|---|---|
| Sex | Males | 27 | 25 | NS |
| Females | 33 | 30 | ||
| Age | 55.3±13.33 | 49.6±13.56 | 0.017 | |
| Employment | Employed | 41 | 42 | NS |
| Unemployed | 19 | 13 | ||
| Education | Elementary | 10 | 14 | NS |
| High School | 29 | 28 | ||
| Undergraduate and above | 21 | 13 | ||
| Duration of ESRD [years] | 10.4±8.73 | 10.3±7.75 | NS | |
| Duration of RRT [months] | 23.1±25.7 | 25.9±26.01 | NS | |
| Hematocrit [%] | 30.9±3.09 | 30.6±3.52 | NS | |
| Albumin [g/dL] | 3.4±0.57 | 3.2±0.44 | NS | |
| Potassium [mg/dL] | 5.1±0.65 | 4.9±0.81 | NS | |
| Calcium [mg/dL] | 8.8±0.97 | 8.9±1.02 | NS | |
| Phosphorus [mg/dL] | 6.1±1.98 | 6.4±1.86 | NS | |
| Creatinine [mg/dL] | 9.5±1.89 | 10.0±2.94 | NS | |
| Urea [mg/dL] | 140.1±41.09 | 135.6±38.77 | NS | |
| Inerdialytic weight change [kg] | 2.1±0.88 | 2.3±0.96 | NS | |
p – level of statistical significance; NS – not statistically significant comparisons; HD – hemodialysed patients; CAPD – continuos peritoneal dialysis; ESRD – end stage renal disease; RRT – renal replacement therapy.
Figure 1Intensity of defense mechanism in studied populations of ESRD patients.
Clusters of coping styles in studied population.
| Cluster | |||
|---|---|---|---|
| #1 (repressors) | #2 | #3 | |
| Number of subjects (HD & CAPD) | 54 (n=42HD & n=12 CAPD) | 57 (n=18HD & n=39 CAPD) | 4 (only n=4 CAPD) |
| Task-oriented coping with ESRD | 24 | 34 | 37 |
| Emotion-oriented coping with ESRD | 21 | 24 | 24 |
| Avoidance-oriented coping with ESRD | 24 | 19 | 19 |
| Intensity of denial defense mechanism | 39 | 22 | 37 |
| Tension and anxiety | 15.3±6.08 | 14.7±6.96 | 10.8±3.30 |
| Depression and dejection | 18.35±11.34 | 24.7±12.31 | 11.8±6.02 |
| Tension and anxiety | 13.3±9.64 | 15.0±8.25 | 9.5±4.93 |
| Vigor and activity | 15.2±6.72 | 15.2±6.19 | 14.8±3.78 |
| Fatigue and inertia | 11.0±5.15 | 9.3±4.32 | 5.3±1.71 |
| Confusion and bewilderment | 11.1±5.41 | 11.3±5.50 | 9.0±3.46 |
| ESRD – anxiety | 42.2±7.52 | 45.8±11.96 | 51.5±2.52 |
| Duration of ESRD | 11.0±8.62 | 9.9±8.13 | 7.5±1.92 |
| Duration of RRT | 27.3±29.1 | 20.3±19.85 | 43±41.8 |
| Energy | 33.3±39 | 22.4±40 | 16.5±33 |
| Pain | 12.5±31 | 12.5±38 | 18.75±31 |
| Emotional reaction | 11.1±33 | 22.2±33 | 11.1±50 |
| Sleep disturbances | 20±50 | 20±45 | 20±60 |
| Social alienation | 20±20 | 0±15 | 20±20 |
| Movement limitations | 12.5±30 | 12.5±25 | 12.5±25 |
HD – hemodialysed patients; CAPD – continuos peritoneal dialysis; ESRD – end stage renal disease; RRT – renal replacement therapy.
Figure 2Different emotional profiles in CAPD vs. HD patients.
Figure 3A comparison of HRQoL among studied subjects.